Revenues for the quarter were $85.8 million, 16 percent up from $73.7 million during the same period in 2003. Of these, Bruker Daltonics contributed $44.8 million, a 7-percent increase year over year, and Bruker AXS contributed $41.8 million, a 32-percent increase over the previous year's quarter.
Research and development expenses climbed to $11.7 million, up from $9.9 million during the year-ago quarter.
Bruker's net income for the quarter was $800,000, or $.01 per diluted share, up from $300,000, or $0 per diluted share, in the fourth quarter of 2003.
As of Dec. 31, Bruker had $78.8 million in cash and short-term investments.